TCRT - היקף יתרות המזומנים של החברה alaunos.com

Focus on insurance reimbursements for personalized treatment of solid tumors drives the liquidity dynamics that the GURU.Markets terminal displays in detail via the cash liquidity chart; meanwhile, 0.00 reflects the latest level of this metric for Alaunos Therapeutics (TCRT). The strategy is based on establishing a patent monopoly to generate long-term rent, while the utilization of high-precision bioreactors in laboratories ensures the production of drug series.
פילוחי מדדים פיננסיים ומדדי שוק עבור Alaunos Therapeutics (TCRT)

This indicator measures the deviation of current liquidity levels from the company's historical averages. By analyzing cash capital dynamics, an investor determines the organization's degree of financial stability. The metric is sensitive to capital expenditures and external financing inflows. For Alaunos Therapeutics (TCRT), this figure is critical due to the absence of revenue. The cash reserve directly determines the company's ability to complete clinical trials for its anti-cancer drugs.